Viewing Study NCT00634205

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-25 @ 3:36 AM
Ignite Modification Date: 2026-03-13 @ 1:27 PM
Study NCT ID: NCT00634205
Status: COMPLETED
Last Update Posted: 2015-02-12
First Post: 2008-03-05
Is NOT Gene Therapy: True
Has Adverse Events: False
Brief Title: Phase II Study of Valproate and Doxorubicin in Malignant Mesothelioma
Sponsor: European Lung Cancer Working Party
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Malignant Mesothelioma View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Mesothelioma View
None Valproate View
None Doxorubicin View
None Chemotherapy View
None Phase II View